Kaufman initated Google (NASDAQ:GOOG) with a "buy" and set a $680 price target according to Briefing.com. The news service also reports that Lehman resumed coverage of Microsoft (NASDAQ:MSFT) with an "equal-weght" rating and a price target of $34.

Thomas Weisel maintained at "overweight" rating on Cephalon (NASDAQ:CEPH) although the FDA rejected broader use of its pain drug Fentora according to the AP.

Douglas A. McIntyre is an editor at 247wallst.com.